Quality control of microelectronic wire bonds

Report evaluates ultrasonic bonding of small-diameter aluminum wire joined to ceramic substrates metalized with thin-film and thick-film gold. Quick testing technique for nondestructive location of poor wire bonds is also presented

Homogeneous and Heterogeneous Front Nucleation in a Bistable Surface Reaction: The NO + CO Reaction on a Cylindrical Pt Crystal

Under continuous flow conditions the oscillatory NO + CO reaction on Pt(100) exhibits bistability in the temperature range below 440 K. In this range, an inactive stationary branch coexists with a reactive oscillatory branch. The transition from the inactive branch, which is only metastable, to the truly stable active branch proceeds via propagating reaction fronts. The associated nucleation process has been investigated in the 10-6 mbar range using photoemission electron microscopy (PEEM) as a spatially resolving method. A Pt sample of cylindrical shape whose surface comprises the highly active orientational range between (100) and (3 10) was used as a catalyst. Depending on the degree of supersaturation, both heterogeneous and homogeneous nucleation have been found. Homogeneous nucleation manifests itself in the occurrence of a so-called “surface explosion” at Tc = 440 K. Below this temperature, heterogeneous nucleation occurs. Depending on the preparation of the inactive state, we observe two different nucleation scenarios which we can tentatively assign to two different kinds of defects

Hyperuricaemia in cyclosporin-treated patients: a GFR-related effect

Background Hyperuricaemia is a well known side-effect of cyclosporin A (CsA) treatment. The pathogenic mechanisms, however, remain controversial. There is no convincing evidence that hyperuricaemia is due to CsA-induced, impaired tubular handling of uric acid. The impact of diminished GFR in this particular context has never been investigated. Methods We prospectively studied plasma uric acid, inulin clearances, and fractional clearances of uric acid in two groups of CsA-treated patients (bone-marrow transplant patients, n=50; renal transplant patients, n=32), and one healthy control group without CsA (living related kidney donors, n=28). Bone-marrow transplant patients were examined before transplantation and 6, 12, 18, 24 months after transplantation, renal transplant patients 1 year after transplantation, and living related kidney donors before and 1 year after unilateral nephrectomy. Results After 1 year of CsA treatment, hyperuricaemia was found in 36% of bone-marrow transplant patients and in 53% of renal transplant patients. Thirty per cent of living related kidney donors were borderline hyperuricaemic 1 year after unilateral nephrectomy. The fractional clearance of uric acid, measured serially in bone-marrow transplant patients did not change significantly over time; it was, however, slightly higher during CsA treatment than after CsA withdrawal. Moreover, the bone-marrow transplant patients' fractional clearance of uric acid was not statistically different from the renal transplant patients' and the living related kidney donors' (values 1 year after transplantation/unilateral nephrectomy: bone-marrow transplant patients, 15.3±2.3%; renal transplant patients, 11.9±0.9%; living related kidney donors, 11.1±0.8%). The GFR at 1 year, measured by inulin clearance, was identical in the CsA-treated groups and slightly higher in the living related kidney donors (bone-marrow transplant patients, 51±6 ml/min per 1.73 m2 renal transplant patients, 49±3 ml/min per 1.73 m2 living related kidney donors, 61±2 ml/min per 1.73 min2). Conclusions There is no evidence for impaired tubular handling of uric acid, induced by a CsA-specific tubulotoxic effect. Hyperuricaemia in CsA-treated transplant patients can therefore be attributed to the cyclosporin associated decrease of GF

Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study

Patients on cyclosporin A (CsA) often develop hyperuricaemia and gout. In transplant patients the use of uricosuric drugs for treating hyperuricaemia may be preferable to allopurinol because of the known interaction of the latter with azathioprine. We therefore prospectively studied the uricosuric efficacy of 100 mg benzbromarone (Bbr;Desuric®) daily in 25 CsA-treated renal transplant patients with stable graft function and hyperuricaemia (>359 μmol/l for females, >491 μmol/l for males). Benzbromarone decreased plasma uric acid from 579±18 μmol/l to 313±24 μmol/l (mean±SEM; P25 ml/min. Due to its excellent efficacy and lack of significant side-effects, benzbromarone appears to be preferable to allopurinol in CsA-treated renal transplant recipients with a creati nine clearance over 25 ml/mi

Sensitivity of activated human lymphocytes to cyclosporine and its metabolites

Alloreactive T cells generated as clones from mixed lymphocyte cultures, or propagated from heart or liver transplant biopsies, were tested for secondary proliferation measured in the primed lymphocyte test in the presence of Cyclosporine A and metabolites fractionated from human bile. Significant differences were observed in Cyclosporine A sensitivity between various cell cultures ranging as high as 100-fold. The liver is the primary site of Cyclosporine A metabolism, which yields a number of hydroxylated and N-dimethylated derivatives that are eventually secreted into the bile. Bile was collected from adult liver transplant patients on Cyclosporine A therapy and following extraction with diethyl ether, separated by high pressure liquid chromatography. Thirteen fractions were tested for their effect on lymphocyte proliferation in concanavalin A activation, mixed lymphocyte cultures and primed lymphocyte test assays. The strongest immunosuppressive effect was found with fraction 8, which contained metabolite M17, which has a single hydroxylation in position 1. Only three other fractions 9, 10, and 13, which contained metabolites M1, M18, and M21, respectively, exhibited immunosuppressive activity, albeit much lower than that of Cyclosporine A. Differences in Cyclosporine A sensitivity among alloreactive T cells followed similar patterns with Cyclosporius A metabolites. Thus, the assessment of the Cyclosporine A effect must consider differences in drug sensitivity of lymphocytes involved in transplant immunity and the generation of metabolites with immunosuppressive activity. © 1988

Nonlocality from N>2 independent single-photon emitters

We demonstrate that intensity correlations of second order in the fluorescence light of N>2 single-photon emitters may violate locality while the visibility of the signal remains below 1/√2≈71%. For this, we derive a homogeneous Bell-Wigner-type inequality, which can be applied to a broad class of experimental setups. We trace the violation of this inequality back to path entanglement created by the process of detection

Creating path entanglement and violating bell inequalities by independent photon sources

We demonstrate a novel approach of violating position-dependent Bell inequalities by photons emitted via independent single photon sources in free space. We trace this violation back to path entanglement created a posteriori by the selection of modes due to the process of detection

Ischemic preconditioning attenuates portal venous plasma concentrations of purines following warm liver ischemia in man

Background/Aims: Degradation of adenine nucleotides to adenosine has been suggested to play a critical role in ischemic preconditioning (IPC). Thus, we questioned in patients undergoing partial hepatectomy whether (i) IPC will increase plasma purine catabolites and whether (ii) formation of purines in response to vascular clamping (Pringle maneuver) can be attenuated by prior IPC. Methods: 75 patients were randomly assigned to three groups: group I underwent hepatectomy without vascular clamping; group II was subjected to the Pringle maneuver during resection, and group III was preconditioned (10 min ischemia and 10 min reperfusion) prior to the Pringle maneuver for resection. Central, portal venous and arterial plasma concentrations of adenosine, inosine, hypoxanthine and xanthine were determined by high-performance liquid chromatography. Results: Duration of the Pringle maneuver did not differ between patients with or without IPC. Surgery without vascular clamping had only a minor effect on plasma purine transiently increased. After the Pringle maneuver alone, purine plasma concentrations were most increased. This strong rise in plasma purines caused by the Pringle maneuver, however, was significantly attenuated by IPC. When portal venous minus arterial concentration difference was calculated for inosine or hypoxanthine, the respective differences became positive in patients subjected to the Pringle maneuver and were completely prevented by preconditioning. Conclusion: These data demonstrate that (i) IPC increases formation of adenosine, and that (ii) the unwanted degradation of adenine nucleotides to purines caused by the Pringle maneuver can be attenuated by IPC. Because IPC also induces a decrease of portal venous minus arterial purine plasma concentration differences, IPC might possibly decrease disturbances in the energy metabolism in the intestine as well. Copyright (C) 2005 S. Karger AG, Basel